NCT04097119View on ClinicalTrials.gov

HDL Function Dietary Supplement Safety and QOL

NAUnknownINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

September 18, 2019

Primary Completion Date

August 30, 2020

Study Completion Date

December 30, 2022

Conditions

HDLHealth, Subjective

Interventions

DIETARY_SUPPLEMENT

Dietary supplementation

Subjects receive a specific dietary supplementation designed to support HDL function daily for 12 weeks

Trial Locations (1)

37205

Hypertension Institute, Nashville

Sponsors

Lead Sponsor

Metagenics, Inc.

All Listed Sponsors

collaborator

Hypertension Institute, Nashville

OTHER

lead

Metagenics, Inc.

INDUSTRY

NCT04097119 - HDL Function Dietary Supplement Safety and QOL | Biotech Hunter | Biotech Hunter